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ABSTRACT
Objective To assess the effectiveness of a primary care
based programme of exercise on prescription among
relatively inactive women over a two year period.
Design Randomised controlled trial.
Setting 17 primary care practices in Wellington, New
Zealand
Participants 1089 women aged 40-74 not undertaking
30 minutes of moderate intensity physical activity on at
least five days of the week
Intervention Brief physical activity intervention led by
nurse with six month follow-up visit and monthly
telephone support over nine months.
Main outcome measure Physical activity assessed at
baseline and 12 and 24 months. Secondary outcomes
were quality of life (SF-36), weight, waist circumference,
blood pressure, concentrations of fasting serum lipids,
glycated haemoglobin (HbA1c), glucose, insulin, and
physical fitness.
Results Mean age was 58.9 (SD 7) years. Trial retention
rates were 93% and 89% at 12 and 24 months,
respectively.Atbaseline,10%ofinterventionparticipants
and 11% of control participants were achieving
150 minutes of at least moderate intensity physical
activity a week. At 12 months rates increased to 43% and
30% and at 24 months to 39.3% and 32.8% (P<0.001),
respectively. SF-36 physical functioning (P=0.03) and
mental health (P<0.05) scores improved more in
intervention compared with control participants, but role
physical scores were significantly lower (P<0.01). There
werenosignificantdifferencesinclinical outcomes.More
falls (P<0.001) and injuries (P=0.03) were recorded in the
intervention group.
Conclusions This programme of exercise on prescription
increased physical activity and quality of life over two
years, although falls and injuries also increased. This
finding supports the use of exercise on prescription
programmes as part of population strategies to reduce
physical inactivity.
Trial registration Australian New Zealand Clinical Trials
Registry (ANZCTR) ANZCTRN012605000490673.
INTRODUCTION
Physical inactivity is a major contributor to chronic
disease, including ischaemic heart disease, stroke,
breast cancer, colon cancer, and type 1 diabetes.
1-4
The United Kingdom government has set a target for
70% of the population to be active by 2020
1—that is,
30 minutes of moderate intensity physical activity five
times a week, as recommended by the US Surgeon
Generalin1996.
5Currently,only40%ofmenand28%
of women in the UK are meeting this target,
6 with
similar proportions among adults in New Zealand.
7
Although it is widely recognised that population
increases in physical activity would have important
public health benefit, few long term evaluations of
physical activity interventions have shown improve-
ments in clinical risk indices with increases in physical
activity.Secondarypreventionstudieshaveshownthat
lifestyle interventions can prevent progression to
diabetes,
8-10 but these studies used interventions that
weretoointensiveandexpensivetobepracticalfroma
populationperspective.Studiesevaluatingstrategiesto
promote physical activity in general populations have
often had methodological limitations including lack of
randomisation or control groups, short duration,
extensive screening and exclusion criteria, and failure
to blind assessors to treatment allocation.
11
“Exerciseonprescription”interventionsthatinvolve
a health professional’s written advice to a patient to be
more physically active have been used with variable
success.
1213 The “green prescription” programme,
which is widely implemented throughout primary
care in New Zealand, has been shown to produce
significant improvements in levels of physical activity
and quality of life among “relatively inactive” (not
undertaking the recommended 30 minutes on at least
fivedaysoftheweek)adultsaged40-79inprimarycare
over a 12 month period.
14 The green prescription
intervention is cost effective
1516 and produced a 10%
incremental increase in adherence to physical activity
amongthosereceivingtheinterventioncomparedwith
thecontrolgroup.Althoughchangesinclinicalindices
were not statistically significant, there were trends
towards reduced systolic and diastolic blood pressure
and total cholesterol concentrations, which were
potentially clinically significant.
17 It was not known,
however, how long the increase in physical activity
would be sustained past one year. We used a
randomised controlled trial design to test the
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METHODS
Participants
Eligibility criteria included women 40-74 who were
physically inactive, as determined by a one question
screening tool: “As a rule, do you do at least half an
hourofmoderateorvigorousexercise(suchaswalking
or a sport) on five or more days of the week?”
1819 The
screening question has been validated against the
longer physical activity questionnaire (the NZPAQ-
LF), which showed that the single item question had
goodsensitivity(76.7%),highspecificity(81.1%),anda
high positive predictive value (86.7%) for identifying
those not achieving the recommended 150 minutes of
moderate level physical activity a week.
19
Participants were excluded if they had a medical
condition that might be adversely affected by increas-
ing their physical activity, as determined by the
physical activity readiness questionnaire (PAR-Q)
20
and subsequent assessment by their own general
practitioner.
Participants were recruited from two sources. The
first source was an existing cohort of 50-74 year old
womenrecruitedbyinvitationletterfromtheirgeneral
practitioner to a previous observational study of
postmenopausal women between 1999 and 2002
from 10 primary care practices in Wellington.
21 The
remainder of the participants were 50-70 year old
women (40-60 years for Maori and Pacific women)
recruited from 13 primary care practices in 2004-5,
including two Maori health clinics. General practi-
tionersatparticipatingpractices were askedto identify
women in the age group from their practice register,
excludingpatientsdeemedinappropriateforparticipa-
tion in a physical activity trial. The general practi-
tioners sent letters to those identified as suitable,
inviting them to participate in a lifestyle study. The
invitation letter requested that women contact the
research team if they were interested in learning more
about the study using the reply slip and prepaid
envelope supplied. A research nurse telephoned those
who replied to determine eligibility and to invite them
to an interview. Interviews were held at one of six
community healthcare settings.
22
Outcome measures
Our primary outcome measure was the proportion of
those achieving the recommended 150 minutes of at
least moderate intensity physical activity, as assessed
bythelongformofthephysicalactivityquestionnaire.
Thisselfreportedquestionnaireasksparticipantsabout
physical activity carried out in the past seven days in
relation to activity type, context, intensity, and dura-
tion.Ithasbeenvalidatedagainstanobjectivemeasure
of energy expenditure (heart rate monitoring) and self
reportedphysicalactivitylogsandagainstthevalidated
international physical activity questionnaire (IPAQ-
Long)
23 in a study of 186 adults.
2425
Secondaryoutcomesincludedqualityoflifeassessed
with the short form36 questionnaire (SF-36)
26; weight,
waist circumference, and blood pressure, recorded by
trained research nurses at each visit; and concentra-
tions of fasting serum lipids, glycated haemoglobin
(HbA1c), glucose, and insulin, measured from blood
samples tested at one laboratory accredited by Inter-
national Accreditation New Zealand (IANZ). Physical
fitness was measured with a three minute step test.
Twelvemonthrecalloffallsandinjurieswasmonitored
foradverseevents.Outcomemeasureswereassessedat
baseline, 12 months, and 24 months. Demographic
characteristics and information about medical condi-
tions and current medications were collected at each
assessment.
Randomisation and blinding
A researcher not involved in the recruitment process
carried out computer generated block randomisation.
We maintained allocation concealment until after we
obtained written consent and completed baseline
measures. After baseline measures the nurse opened
sequentially numbered opaque envelopes containing
theallocatedtreatmentgroup(interventionorcontrol).
Returned to sender (n=317)
No reply (n=2560)
Excluded (n=1268)
  Did not meet inclusion criteria (n=1108)
  Unwilling to participate (n=160)
Declined (n=572)
Sent letter of invitation to participate in 2004-2005 (n=5913)
Replies received (n=3036)
Willing to be assessed (n=2464)
Recruitment target met before assessment (n=107)
Assessed for eligibility (n=2357)
Randomised (n=1089)
Allocated to control (n=545)
  Received usual care
Allocated to intervention (n=544):
  Received allocated intervention:
    Telephone counselling (n=535)
    Attended 6 month nurse visit (n=514)
  Did not receive full intervention (n=30):
    Withdrew (n=7)
    Moved away/not available (n=23)
Attended 12 month visit (n=501)
Reasons for not attending:
  Dropped out (n=25)
  Not contactable (n=7)
  Unable to attend (n=11)
Attended 12 month visit (n=507)
Reasons for not attending:
  Dropped out (n=25)
  Not contactable (n=7)
  Unable to attend (n=11)
Group allocation
12 month
follow-up
(n=1008)
Attended 24 month visit (n=487)
Reasons for not attending:
  Dropped out (n=31)
  Not contactable (n=7)
  Unable to attend (n=19)
Attended 24 month visit (n=487)
Reasons for not attending:
  Dropped out (n=21)
  Not contactable (n=12)
  Unable to attend (n=25)
24 month
follow-up
(n=974)
Fig 1 | Recruitment and retention of participants
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follow-up visits were blind to group allocation, and
participantswereasked nottodiscussgroup allocation
with the assessing nurse.
Intervention
The intervention we assessed was built on an existing
primary care programme, the green prescription, in
whichthegeneralpractitionerorpracticenursebriefly
counsels (7-13 minutes) patients using motivational
interviewing techniques to increase physical activity
amongthosewhoarephysicallyinactive.Thedetailsof
the exercise advice are written on a “green script,”
whichisgiventothepatientandfaxedtoacommunity
based exercise facilitator who provides telephone
support over a three month period, assisting with
choice of activity, goal setting, and ways to overcome
personalbarrierstophysicalactivity.
1427Inourstudya
primary care nurse delivered the green prescription
and follow-up was extended to include telephone calls
over a nine month period (average of five calls, each
lasting 15 minutes) with an added 30 minute visit with
the primary care nurse at six months. The recom-
mended goal was moderate intensity physical activity
such as brisk walking, with a goal of achieving
30 minutes five days a week. The nurse noted clinical
details including weight, height, waist circumference,
smokingstatus,andanyrelevantmedicalconditionson
the faxed script.
During the visit at six months the nurse established
whether the participant had increased her physical
activity to the target level, provided encouragement
andmotivation,andmeasuredbloodpressure,weight,
and waist circumference. Tools to assist with choosing
appropriate types of activities and motivational aids,
suchasfridgemagnetsand activityrecordcharts,were
also offered. Further details about the intervention are
available elsewhere.
22 Control participants received
usual care from their primary care practice.
Sample size calculation
Based on means, standard deviations, and levels of
physical activity achieved in previous trials, we
calculated we needed a sample size of 880 to detect a
minimumdifferencebetweenthegroupsof7%change
intheproportionofwomenreachingthetargetlevelof
150 minutes of at least moderate intensity physical
activity each week, allowing for a 10% attrition rate
(α=0.05, 80% power).
1428 This sample size was ade-
quate to detect as significant, a difference between the
groups in secondary outcomes of 3 mm Hg diastolic
blood pressure, 4 mm Hg systolic blood pressure,
0.25 mmol/l serum cholesterol, 0.1 mmol/l high
density lipoprotein cholesterol, and 0.2% HbA1c.
Statistical analyses
We carried out an intention to treat analysis of all
participants enrolled in the study according to alloca-
tion of randomisation, regardless of adherence to
physical activity. For missing data at follow-up assess-
ments, we assumed no change from baseline. Final
analyses were undertaken with regression models,
adjusted for repeated measures and baseline values, in
SAS version 9.2. Non-normally distributed data were
log transformed.
RESULTS
We recruited participants from 17 primary healthcare
practices in Wellington and in 2004-5 enrolled 1089
less active women. Figure 1 shows the progression of
participants through the trial. Characteristics of the
study participants were balanced at baseline (tables 1
and 2). Trial retention rates were 93% and 89% at 12
and 24 months, respectively.
Bothgroupsincreasedtheirphysicalactivityoverthe
twoyears.Meanphysicalactivitylevels,however,were
higher (P=0.01) and a greater proportion reached the
target of 150 minutes of at least moderate intensity
physical activity in the intervention group compared
with the control group at 12 months (233 (43%) v 165
(30%), (P<0.001), with levels declining but still
Table 1 |Characteristics of participants in intervention and control groups at baseline. Figures
are means (SD) unless stated otherwise
Characteristic Intervention (n=544) Control (n=545)
Age (years) 59.1 (6.8) 58.7 (6.9)
Body mass index 29.2 (5.8) 29.2 (6.1)
Leisure exercise/week (mins) 58 (84) 60 (91)
Quality of life (SF-36):
Role physical 90.4 (18.7) 89.8 (14.4)
Bodily pain 72.0 (23.0) 74.2 (23.3)
Vitality 59.0 (14.2) 59.5 (13.5)
Social functioning 89.2 (18.2) 89.2 (18.3)
Role emotional 92.2 (16.5) 93.4 (14.3)
Mental health 71.2 (11.9) 71.7 (10.6)
General health 76.4 (17.9) 78.0 (17.9)
No (%) of participants:
Current smokers 67 (12) 70 (13)
Lower socioeconomic status
29 87 (16) 75 (14)
With tertiary education 230 (42) 246 (45)
European 411 (76) 435 (80)
Maori or Pacific Islander 79 (15) 64 (12)
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Fig2 |Proportionofparticipantsachievingatleast150minutes
of moderate intensity physical activity at baseline and 12 and
24 months
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(33%), fig 2 and table 2). SF-36 physical functioning
(P=0.03) and mental health (P<0.05) subscores were
also significantly better in the intervention group at 12
and 24 months, although role physical scores were
lower in the intervention group (P<0.01) (table 3).
There were no significant differences between groups
in any of the secondary clinical outcomes (table 2).
There was also no significant difference in the
proportions on antihypertensive (P=0.90) or lipid
lowering (P=0.80) drugs between the groups over the
two years. Adjustment for medication did not sig-
nificantly change the results on blood pressure and
lipid outcome in sensitivity analyses. More falls
(P<0.001) and injuries (P=0.03) were recorded in the
intervention group compared with the control group
overthetwoyears(table 2).Wedeviatedfromplanned
analyses in the omission of data relating to physical
fitness (a secondary outcome) as the potential for
inaccuracies in the recording of pulse rate meant the
quality of the data was questionable and not analysed
here.
Although a large proportion of control participants
increased their physical activity during the trial, only
2.4% (11/480 women contacted) recalled having
received a green prescription from their doctor or
nurse during the data collection period.
DISCUSSION
Exercise on prescription can increase physical activity
and improve some variables of quality of life over two
years among physically inactive women recruited
through primary care compared with usual care. In
our study, however, the increased levels of physical
activity did not produce significant improvements in
clinical or biochemical variables, and there were
increases in falls and injuries and a reduction in the
SF-36 role physical score.
The increasesin physicalactivity were most marked
at 12 months. We expected deterioration over time in
physical activity after 12 months and, although levels
haddeclinedby24months,theywerestillsubstantially
higher than at baseline and significantly higher in the
intervention group than in the control group.
Comparison with other studies
Thetwoyearfollow-upmakesthisstudyoneofthefirst
primary prevention physical activity trials to show a
significant effect of physical activity counselling over
two years. The activity counselling trial compared two
behavioural counselling approaches of different inten-
sities (intervention arms) with brief advice from a
physician and written materials (control arm). The
intensive interventions produced more improvement
incardiorespiratoryfitnessinwomenbutnotmenover
two years, but there was no change in self reported
physical activity in men or women.
30 However, there
wasnotruecontrolgroup.Theactivitycounsellingtrial
also assessed adverse events and found that each year
about 30% sustained a musculoskeletal event after the
interventioninallthreegroups,whichwashigherthan
Table 2 |Primary and secondary clinical outcome measures and adverse events in intervention
and control groups at baseline and 12 and 24 months. Values are means (SD) unless stated
otherwise
Outcome measures Intervention (n=544) Control (n=545) P value*
Primary
No (%) completing at least 150 minutes physical activity/week:
Baseline 56 (10) 62 (11)
<0.001 12 months 233 (43) 165 (30)
24 months 214 (39) 179 (33)
Median (interquartile range) minutes physical activity/week:
Baseline 30 (0-90) 30 (0-90)
0.01† 12 months 120 (0-210) 75 (0-170)
24 months 105 (0-205) 90 (0-190)
Secondary
Systolic blood pressure (mm Hg):
Baseline 122.8 (0.7) 123.4 (0.8)
0.50 12 months 120.6 (0.7) 121.9 (0.7)
24 months 119.1 (0.7) 119.5 (0.7)
Diastolic blood pressure (mm Hg):
Baseline 73.8 (0.4) 74.7 (0.4)
0.96 12 months 71.5 (0.4) 72.4 (0.4)
24 months 71.6 (0.4) 71.7 (0.4)
Weight (kg):
Baseline 73.2 (0.6) 72.7 (0.6)
0.60 12 months 72.6 (0.6) 72.7 (0.6)
24 months 72.6 (0.6) 72.5 (0.6)
Waist circumference (cm):
Baseline 86.7 (0.6) 86.2 (0.6)
0.70 12 months 87.3 (0.5) 87.3 (0.5)
24 months 88.7 (0.6) 88.7 (0.6)
Cholesterol (mmol/l):
Baseline 6.10 (0.05) 6.03 (0.05)
0.90 12 months 5.86 (0.04) 5.83 (0.04)
24 months 5.65 (0.04) 5.59 (0.04)
High density lipoprotein cholesterol (mmol/l):
Baseline 1.65 (0.02) 1.63 (0.02)
0.40 12 months 1.73 (0.02) 1.71 (0.02)
24 months 1.66 (0.02) 1.66 (0.02)
HbA1c (%):
Baseline 5.55 (0.02) 5.46 (0.03)
0.60 12 months 5.70 (0.02) 5.61 (0.02)
24 months 5.74 (0.02) 5.69 (0.02)
Insulin (pmol/l):
Baseline 41.3 (1.2) 41.0 (1.2)
0.70 12 months 45.8 (1.2) 46.7 (1.3)
24 months 48.6 (1.3) 48.4 (1.3)
Glucose (mmol/l):
Baseline 5.02 (0.03) 4.96 (0.02)
0.99 12 months 4.97 (0.03) 4.96 (0.03)
24 months 4.92 (0.03) 4.87 (0.02)
Adverse events
No (%) of falls:
Baseline 138 (25) 155 (29)
<0.001 12 months 158 (32) 127 (25)
24 months 179 (37) 143 (29)
No (%) of injuries:
Baseline 77 (14) 103 (19)
0.03 12 months 91 (18) 86 (17)
24 months 92 (19) 66 (14)
*Analyses took into account repeated measures and adjusted for baseline values. Data that were not normally
distributed were log transformed.
†Significance calculated after log transformation of data because of skewed nature of data.
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the rate of falls in our trial was about 30%.
The recently reported “ProActive” randomised
controlled trial in primary care involved adults with a
family history of diabetes who were randomised to a
one year behaviour change programme (delivered by
telephoneorfacetoface)ortoacontrolgroup(givenan
advice leaflet on physical activity).
31 At one year,
daytimephysicalactivityhadimprovedinbothgroups,
buttherewerenosignificantdifferencesbetweenthem.
Similartothepresentstudy,theProActivetrialshowed
improvements on some measures of quality of life but
no improvements in clinical variables.
31 The positive
impactofphysicalactivityonqualityoflife,inaddition
to cardiovascular benefits, has been well documented
and is associated with positive health outcomes.
3233
The incremental increase in physical activity in our
study was more than was found with the briefer green
prescriptioninterventionoveroneyear(12.5%v10%at
12 months) and similar improvements were observed
in quality of life variables.
14 In the earlier green
prescription trial, participants indicated that more
follow-up with health professionals might help with
adherence to physical activity.
14 The current inter-
vention provided this extended follow-up.
Strengths and limitations
The strengths of this study include the large sample
size, the inclusion of a representative sample of ethnic
minorities (Maori and Pacific people), high retention
rates at two years (89%), and blinding of outcome
assessment. Adverse events were monitored and cost
variableswerecollectedforsubsequentanalysisofcost
effectiveness. The intervention could be used beyond
the research setting as the simple version of the green
prescription is already disseminated widely through-
out primary care in New Zealand; in 2007, 87% of
general practitioners issued a green script and over
20000 patients were supported nationally.
34 Further-
more, the use of a simple and validated question to
identifyinactivepatients
19canalsobeusedineveryday
primarycaretoidentifythosewhowouldbenefitfroma
physical activity intervention.
Limitationsofthisstudyincludetheinabilitytoblind
participants to the intervention. Participants in both
groups showed a high uptake of physical activity. This
positiveeffectinthecontrolgroupmighthavereflected
atrendinthepopulation,participationinastudyabout
physical activity, or the fact that those who agreed to
take part in a trial were more motivated to change
anyway than those who declined. Furthermore, the
time spent with the research nurse at each assessment
might have acted as an intervention in itself. Contam-
ination is unlikely as few participants in the control
group reported having received a green prescription
(the basic version of the intervention used) during the
study.
Although participants were recruited through pri-
mary care, their participation was by special invitation
and the delivery of the intervention was not part of
routine care. Even so, the basic green prescription is
alreadypartofroutinecareinNewZealand.Thefocus
onolderwomen,theselfselectednatureofparticipants,
and the overall participation rate of 19.5% (1089/5913
invited minus 317 returned to sender) might further
limit the generalisability of results to younger women
and to men. Of those assessed for eligibility, however,
we excluded 47% as they were already physically
active, which is in line with national data on physical
activity levels.
7
The absence of a significant difference in secondary
clinicalendpointsisnotsurprisingandmightbepartly
due to the increase in overall physical activity in the
control group. Therefore, while this sample size was
large enough to detect quite small differences in
physical activity between the groups, it was not large
enough to detect as significant any differences in
clinicaloutcomes.Thereis,however,awellestablished
relation between increasing physical activity and
health benefit, so showing a small increase across a
populationhashealthbenefitsandcanbecosteffective
considering the low cost of the intervention.
16
The use of a self reported measure as the main
outcome is a potential weakness but, when validated
against an objective measure, the physical activity
questionnaire performed well.
2425 Objective measures
of physical activity, such as activity monitors, would
have added to the validity of these findings. Adverse
events of falls and injuries were also self reported so
were open to recall bias.
Table 3 |Mean change (95% confidence interval) in quality of life outcomes in intervention and control groups from baseline to
12 and 24 months
SF-36 subscale
Intervention Control
Pvalue* 12 months 24 months 12 months 24 months
Physical function 2.17 (1.12 to 3.21) −0.09 (−1.13 to 0.94) 0.07 (−0.97 to 1.11) −0.91 (−1.94 to 0.12) 0.03
Role physical −1.09 (−2.80 to 0.62) −2.03 (−3.84 to −0.21) 1.64 (−0.07 to 3.35) 1.35 (−0.47 to 3.16) <0.01
Bodily pain −0.53 (−2.56 to 1.49) −1.56 (−3.67 to 0.56) 0.28 (−1.74 to 2.30) −0.40 (−2.51 to 1.71) 0.5
Vitality 2.24 (1.33 to 3.15) 1.63 (0.72 to 2.54) 0.98 (0.09 to 1.87) 1.88 (0.97 to 2.78) 0.3
Social functioning 1.21 (−0.55 to 2.97) −1.14 (−2.95 to 0.66) 0.47 (−1.27 to 2.22) 0.16 (−1.64 to 1.96) 0.8
Role emotional 1.28 (−0.17 to 2.72) 2.02 (0.59 to 3.45) 0.05 (−1.40 to 1.49) 0.73 (−0.69 to 2.16) 0.2
Mental health 1.73 (0.82 to 2.63) 1.49 (0.54 to 2.44) 0.51 (−0.39 to 1.42) 0.39 (−0.56 to 1.34) <0.05
General health 2.69 (1.54 to 3.84) 1.26 (0.02 to 2.51) 1.17 (0.03 to 2.32) 0.20 (−1.05 to 1.44) 0.09
*Analyses took into account repeated measures and adjusted for baseline values.
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Programmes of exercise on prescription can produce
sustained increases in physical activity among less
active middle aged and older women over two years.
Furthermore, a second face to face session with
prolonged monthly telephone support might improve
the effectiveness of the current brief interventions
delivered in primary health care.
14 There is now
widespread acceptance that an increase in physical
activity to recommended levels has considerable
health benefits, including an estimated 20-30% reduc-
tion in all cause mortality.
13536 Therefore, reducing
physical inactivity by 10% across a primary care
population of less active adults could have consider-
able health impact.
Improving the modifiable risk factors of physical
inactivity and obesity at a populationlevel will require
multiple measures including legislation, public health
mediamessages,andenvironmentalchangesaswellas
dietary and physical activity programmes.
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